Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$6.23 - $11.12 $2,591 - $4,625
-416 Closed
0 $0
Q1 2022

Apr 19, 2022

SELL
$7.89 - $12.48 $1,656 - $2,620
-210 Reduced 33.55%
416 $4,000
Q4 2021

Jan 24, 2022

BUY
$9.82 - $12.44 $265 - $335
27 Added 4.51%
626 $7,000
Q3 2021

Oct 19, 2021

BUY
$8.74 - $11.84 $349 - $473
40 Added 7.16%
599 $6,000
Q2 2021

Jul 13, 2021

BUY
$8.71 - $10.72 $3,562 - $4,384
409 Added 272.67%
559 $5,000
Q1 2021

May 03, 2021

SELL
$9.2 - $23.86 $423 - $1,097
-46 Reduced 23.47%
150 $1,000
Q4 2020

Feb 04, 2021

BUY
$13.47 - $24.89 $1,347 - $2,489
100 Added 104.17%
196 $5,000
Q3 2020

Oct 26, 2020

BUY
$12.89 - $15.89 $219 - $270
17 Added 21.52%
96 $1,000
Q2 2020

Jul 06, 2020

SELL
$8.86 - $15.69 $336 - $596
-38 Reduced 32.48%
79 $1,000
Q1 2020

Apr 13, 2020

SELL
$6.63 - $11.16 $318 - $535
-48 Reduced 29.09%
117 $1,000
Q4 2019

Feb 05, 2020

BUY
$7.48 - $10.75 $1,234 - $1,773
165 New
165 $2,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.64B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.